Survival for persistent trophoblastic disease and choriocarcinoma is very high. Nearly all women are cured.

The statistics here are intended as a general guide and can't tell you what is likely to happen in your individual case.

Your doctor can give you more information about your own outlook (prognosis).

You can also talk about this with the Cancer Research UK nurses on freephone 0808 800 4040, from 9am to 5pm, Monday to Friday.

Survival by risk group

Chemotherapy works very well in most women with persistent trophoblastic disease and choriocarcinoma. Women who need chemotherapy are divided into 2 different risk groups - low risk and high risk disease. 

There are no UK wide statistics for persistent trophoblastic disease and choriocarcinoma.

Statistics are available from research undertaken at one of the specialist UK centres that treats these conditions.

Low risk disease

All women (100%) with low risk disease are cured. 

High risk disease

Over 90 out of 100 women (over 90%) with high risk disease are cured. 

  • Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009.
    A Sita-Lumsden and others
    British Journal of Cancer. 2012 November 20 Volume 107, Issue 11, Pages 1810-4.

  • EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    C Alifrangis C and others
    Journal of Clinical Oncol. 2013 January 10, Volume 31, Issue 2, Pages 280-6

Last reviewed: 
18 Jul 2019

Related links